Mawson Infrastructure Group Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Mawson Infrastructure Group Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $39.75M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $59.27M | Mar 31, 2026 |
| FY2023 | Dec 31, 2023 | $43.57M | Apr 1, 2024 |
| FY2023 | Dec 31, 2022 | $84.39M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $43.86M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $4.45M | Mar 21, 2022 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.34M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $20.28M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $15.01M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $36.67M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $33.96M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $1.29M | Mar 21, 2022 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($23.66M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($46.13M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($60.42M) | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | ($52.76M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($44.96M) | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | ($5.06M) | Mar 21, 2022 |
| FY2020 | Dec 31, 2019 | ($3.45M) | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | ($3.28M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($2.97M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($1.14M) | Mar 29, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($19.29M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($31.15M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($60.32M) | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | ($44.09M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($42.67M) | Mar 23, 2023 |
| FY2020 | Dec 31, 2020 | ($2.44M) | Mar 1, 2021 |
| FY2020 | Dec 31, 2019 | ($3.17M) | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | ($3.63M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($1.48M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($1.03M) | Mar 29, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $434.0K | Mar 1, 2021 |
| FY2020 | Dec 31, 2019 | $492.0K | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $694.0K | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $450.0K | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $240.0K | Mar 29, 2018 |
| FY2017 | Dec 31, 2015 | $1.20M | Mar 29, 2018 |
| FY2015 | Dec 31, 2014 | ($721.0K) | Mar 2, 2016 |
| FY2014 | Dec 31, 2013 | ($1.76M) | Mar 25, 2015 |
| FY2013 | Dec 31, 2012 | $1.8K | Mar 27, 2014 |
| FY2012 | Dec 31, 2011 | $216 | Mar 27, 2013 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $22.65M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $18.31M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $19.18M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $25.85M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $16.06M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $2.48M | Mar 21, 2022 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($6.90M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $3.56M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($2.55M) | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $14.26M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $22.95M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | ($185.1K) | Mar 21, 2022 |
| FY2020 | Dec 31, 2019 | ($2.06M) | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | ($2.21M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($1.36M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($874.0K) | Mar 29, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $5.35M | Apr 1, 2024 |
| FY2023 | Dec 31, 2022 | $49.98M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $76.80M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $5.51M | Mar 21, 2022 |
| FY2019 | Dec 31, 2018 | $5.0K | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $4.0K | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $1.0K | Mar 29, 2018 |
| FY2016 | Dec 31, 2015 | $3.0K | Mar 23, 2017 |
| FY2014 | Dec 31, 2013 | $2.0K | Mar 25, 2015 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $57.44M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $61.44M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $84.77M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $133.33M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $145.29M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $9.80M | Mar 21, 2022 |
| FY2020 | Dec 31, 2019 | $1.18M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $3.40M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $595.0K | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $69.0K | Mar 29, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $60.56M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $64.68M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $54.38M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $57.16M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $30.71M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $2.23M | Mar 21, 2022 |
| FY2019 | Dec 31, 2019 | $250.0K | Mar 30, 2020 |
| FY2019 | Dec 31, 2018 | $250.0K | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $250.0K | Apr 1, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($3.12M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($3.24M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $29.24M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $77.07M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $114.75M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $7.59M | Mar 21, 2022 |
| FY2020 | Dec 31, 2019 | $535.0K | Mar 1, 2021 |
| FY2020 | Dec 31, 2018 | $212.0K | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | ($3.10M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2016 | ($831.0K) | Apr 1, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($252.45M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($228.80M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($182.67M) | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | ($122.26M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($71.12M) | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | ($26.16M) | Mar 21, 2022 |
| FY2020 | Dec 31, 2019 | ($33.90M) | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | ($30.00M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($26.45M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($23.48M) | Mar 29, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.27M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $6.09M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $4.48M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $946.3K | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $5.47M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $1.11M | Mar 21, 2022 |
| FY2020 | Dec 31, 2019 | $718.0K | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $3.18M | Mar 30, 2020 |
| FY2019 | Dec 31, 2017 | $215.0K | Mar 30, 2020 |
| FY2018 | Dec 31, 2016 | $40.0K | Apr 1, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $25.18M | Mar 31, 2026 |
| FY2024 | Dec 31, 2024 | $20.92M | Mar 28, 2025 |
| FY2023 | Dec 31, 2023 | $19.35M | Apr 1, 2024 |
| FY2022 | Dec 31, 2022 | $28,120.48B | Mar 23, 2023 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (20) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | (51) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | (3) | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | (4) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | (4) | Mar 23, 2023 |
| FY2013 | Dec 31, 2013 | 0 | Mar 27, 2014 |
| FY2013 | Dec 31, 2012 | 0 | Mar 27, 2014 |
| FY2012 | Dec 31, 2011 | 0 | Mar 27, 2013 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (20) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | (51) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | (3) | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | (4) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 23, 2023 |
| FY2013 | Dec 31, 2013 | 0 | Mar 27, 2014 |
| FY2013 | Dec 31, 2012 | 0 | Mar 27, 2014 |
| FY2012 | Dec 31, 2011 | 0 | Mar 27, 2013 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 939,618 | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 939,618 | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 16.64M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | 13.63M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | 13.63M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | 70.75M | Mar 21, 2022 |
| FY2020 | Dec 31, 2019 | 15.87M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | 8.96M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | 4.35M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | 3.02M | Mar 29, 2018 |